Hanmi Pharm. Co.  Ltd

Hanmi Pharm. Co. Ltd


Company description

Hanmi has shown remarkable growth since its foundation in 1973 and has now become the most spotlighted company among Korean pharmaceutical companies. We are proud to be known as a global leader in the quality API production of cephalosporins, cardiovascular, anti-diabetics, gastrointestinal, and CNSs. The facilities have been inspected and approved by UK MHRA, German BSG, Australian TGA, and US FDA. Hanmi has been successfully developed and marketed New Combination drug and a series of IMDs with its own patented process, and also succeeded in developing LAPSCOVERY technology, which is enhancing the half-life time for bio-products.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Primary business activity Manufacturer

Upcoming events

13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 5B90 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 90F85 See our Exhibitor Profile   See full Exhibitor List
Hanmi Pharm. Co. Ltd

Contact information




View all contact information